Analysen von Andrew Baum
| 22.05.18 | Roche Neutral | Citigroup Corp. | |
| 18.10.17 | Roche Neutral | Citigroup Corp. | |
| 08.09.17 | GSK Neutral | Citigroup Corp. | |
| 27.07.17 | GSK Neutral | Citigroup Corp. | |
| 25.07.17 | GSK Neutral | Citigroup Corp. | |
| 05.07.17 | GSK Neutral | Citigroup Corp. | |
| 23.05.16 | Novartis Neutral | Citigroup Corp. | |
| 18.05.16 | Novartis Neutral | Citigroup Corp. | |
|
Werbung
|
|||
| 29.03.16 | Novartis Neutral | Citigroup Corp. | |
| 05.11.15 | GSK Neutral | Citigroup Corp. | |
| 23.10.15 | GSK Neutral | Citigroup Corp. | |
| 09.10.15 | Roche Neutral | Citigroup Corp. | |
| 09.09.15 | GSK Neutral | Citigroup Corp. | |
| 21.05.15 | GSK neutral | Citigroup Corp. | |
| 29.04.15 | Roche Neutral | Citigroup Corp. | |
| 29.04.15 | Sanofi Neutral | Citigroup Corp. | |
| 07.04.15 | Roche Neutral | Citigroup Corp. | |
| 09.02.15 | Roche Neutral | Citigroup Corp. | |
| 08.07.14 | Merck Neutral | Citigroup Corp. | |
| 28.05.14 | Merck Neutral | Citigroup Corp. | |
| 31.08.10 | Sanofi equal-weight | Morgan Stanley | |
| 15.07.10 | GSK halten | Morgan Stanley | |